Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • LejzerowiczF
    Junior Member
    • Mar 2015
    • 2

    Metagenomic amplicon sequences-to-sample misidentification description and solution

    Hi All,

    I cannot resist asking the community about its feeling/experience on the underrated issue we've been studying (open access: http://nar.oxfordjournals.org/conten.../18/nar.gkv107).
    It's surprising that loads of cross-contaminations created by the switching of tags/indices sequences appended to amplification primers and used for sample demultiplexing aren't addressed much... Did you noticed this in your metagenomic amplicon datasets?

    Cheers to all!
  • bunce
    Member
    • Sep 2012
    • 55

    #2
    Dear Franck,
    A really fascinating paper - thanks for sharing - which together with this recent paper ( http://onlinelibrary.wiley.com/doi/1...12402/abstract) really show up the issue. Clearly people need to think hard about the workflows.

    you asked for feeling/experience so I thought I would chip in a few (well, five) thoughts.

    (1) completely agree you need to get tags onto samples in the first round of PCR. To not do this is molecular biology madness.

    (2) Your 2nd round of PCR (8 cycles is still a long-primer PCR) - less cycles, granted - but still subject to the same bias and a 1-step long-primer approach.

    (3) So I guess I only disagree with your recommendation VII in the conclusion (which you don’t present data on)…..there are issues (primarily efficiency, particularly with low-template samples) with long-primer approaches to library generation - but this tag jumping does not happen if you do go down this 1-step path. You might get intra-sample chimeras but not inter-sample ones (the latter of which are a much larger issue). We routinely spike-in untagged primers into these reactions - this may help to alleviate some of the efficiency drops. We monitor all steps using qPCR and don’t re-use the same forward/reverse index to avoid contamination as we are doing sensitive work (aDNA etc). I guess there is a trade off in efficiency with long-primer approach v's mis-tagging/contamination risks with the 2-step approach…. in my mind it is not a question of what is ‘better’ they are different.

    (4) You cite the Berry paper as the reason for your recommendation #VII. Which is an interesting look at 1-step v’s 2-step approaches But it is a single primer set, has no spike-in of untagged primers, no qPCR to look at template input/efficiency and the differences encountered are not huge…. (fig 2a). I like this paper, but it is not ‘definitive’…. and in fact some of the ‘extra' diversity using a 2-step my have in fact been generated by the mis-tagging that you suggest.

    (5) In our lab we use either (a) single-step long-primer fusions on ‘good’ samples… and (b) primer+index PCRs which we ligate adapters on in a PCR-free ligation. Through this set-up we are (desperately) trying to avoid a 2nd round PCR. 2nd Round PCRs are (as you paper elegantly points out) the source of mis-stagging and are also a contamination risk.

    So, thanks again for the paper - the LSD solution to the mis-tagging is neat…. but a carefully implemented 1-step approach can side-step many of the issues with this as well.

    Cheers, Mike

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM
    • GATTACAT
      Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
      by GATTACAT
      Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
      07-01-2026, 11:43 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-07-2026, 11:05 AM
    0 responses
    34 views
    0 reactions
    Last Post SEQadmin2  
    Working...